Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07169630 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 249 record versions are listed below. See every version on ClinicalTrials.gov ↗

  1. Minor Start date: Oct 19, 2026 to Oct 20, 2026
  2. Minor Start date: Oct 18, 2026 to Oct 19, 2026
  3. Minor Start date: Oct 14, 2026 to Oct 18, 2026
  4. Minor Start date: Oct 13, 2026 to Oct 14, 2026
  5. Minor Start date: Oct 12, 2026 to Oct 13, 2026
Show 45 earlier versionsHide 45 earlier versions
  1. Minor Start date: Oct 11, 2026 to Oct 12, 2026
  2. Minor Start date: Oct 8, 2026 to Oct 11, 2026
  3. Minor Start date: Oct 7, 2026 to Oct 8, 2026
  4. Minor Start date: Oct 6, 2026 to Oct 7, 2026
  5. Minor Start date: Oct 5, 2026 to Oct 6, 2026
  6. Minor Start date: Oct 4, 2026 to Oct 5, 2026
  7. Minor Start date: Sep 20, 2026 to Oct 4, 2026
  8. Minor Start date: Sep 17, 2026 to Sep 20, 2026v237
  9. Minor Start date: Sep 16, 2026 to Sep 17, 2026v236
  10. Minor Start date: Sep 15, 2026 to Sep 16, 2026v235
  11. Minor Start date: Sep 14, 2026 to Sep 15, 2026v234
  12. Minor Start date: Sep 10, 2026 to Sep 14, 2026v233
  13. Minor Start date: Sep 9, 2026 to Sep 10, 2026v232
  14. Minor Start date: Sep 8, 2026 to Sep 9, 2026v231
  15. Minor Start date: Sep 7, 2026 to Sep 8, 2026v230
  16. Minor Start date: Sep 6, 2026 to Sep 7, 2026v229
  17. Minor Start date: Sep 3, 2026 to Sep 6, 2026v228
  18. Minor Start date: Sep 2, 2026 to Sep 3, 2026v227
  19. Minor Start date: Sep 1, 2026 to Sep 2, 2026v226
  20. Minor Start date: Aug 31, 2026 to Sep 1, 2026v225
  21. Minor Start date: Aug 30, 2026 to Aug 31, 2026v224
  22. Minor Start date: Aug 27, 2026 to Aug 30, 2026v223
  23. Minor Start date: Aug 26, 2026 to Aug 27, 2026v222
  24. Minor Start date: Aug 25, 2026 to Aug 26, 2026v221
  25. Minor Start date: Aug 24, 2026 to Aug 25, 2026v220
  26. Minor Start date: Aug 23, 2026 to Aug 24, 2026v219
  27. Minor Start date: Aug 20, 2026 to Aug 23, 2026v218
  28. Minor Start date: Aug 19, 2026 to Aug 20, 2026v217
  29. Minor Start date: Aug 18, 2026 to Aug 19, 2026v216
  30. Minor Start date: Aug 17, 2026 to Aug 18, 2026v215
  31. Minor Start date: Aug 16, 2026 to Aug 17, 2026v214
  32. Minor Start date: Aug 13, 2026 to Aug 16, 2026v213
  33. Minor Start date: Aug 12, 2026 to Aug 13, 2026v212
  34. Minor Start date: Aug 11, 2026 to Aug 12, 2026v211
  35. Minor Start date: Aug 10, 2026 to Aug 11, 2026v210
  36. Minor Start date: Aug 7, 2026 to Aug 10, 2026v209
  37. Minor Start date: Aug 6, 2026 to Aug 7, 2026v208
  38. Minor Start date: Aug 5, 2026 to Aug 6, 2026v207
  39. Minor Start date: Aug 4, 2026 to Aug 5, 2026v206
  40. Minor Start date: Aug 3, 2026 to Aug 4, 2026v205
  41. Minor Start date: Aug 2, 2026 to Aug 3, 2026v204
  42. Minor Start date: Jul 30, 2026 to Aug 2, 2026v203
  43. Minor Start date: Jul 29, 2026 to Jul 30, 2026v202
  44. Minor Start date: Jul 28, 2026 to Jul 29, 2026v201
  45. Minor Start date: Jul 27, 2026 to Jul 28, 2026v200
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: About 5 million adults in the United States have age-related brain disorders. These include Alzheimer disease (AD), mild cognitive impairment (MCI), and other dementias. The number of people with these disorders will likely increase as the population ages and life span increases. Inflammation is thought to play a role in AD and MCI. Researchers want to know if an enzyme called PDE4B increases inflammation in people with AD or MCI. Objective: To test whether medical imaging using a new radiotracer (\[18F\]PF-06445974) can measure PDE4B in the brains of people with AD or MCI. Eligibility: People aged 50 years and older with AD or MCI. Healthy volunteers are also needed. Design: Participants will have up to 5 clinic visits with 3 imaging scans of the brain. They will have be screened. They will have a physical exam with blood tests. This will include tests of their heart and nerve function, including memory. Participants will have 2 positron emission tomography (PET) scans. One will use a standard radiotracer. The other will use the study radiotracer. They will receive each tracer through a tube attached to a needle inserted into a vein. During the scan with the study tracer, participants will have a second tube inserted into a vein in the wrist; this tube will be used to draw blood during the scan. Participants will lie on a bed that slides into a doughnut-shaped machine. These visits will take about 6 hours each. Participants will have 1 magnetic resonance imaging (MRI) scan. They will lie on a bed that slides into a cylinder. This visit will take up to 2 hours....
Trial Details
NCT Number NCT07169630
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions
(from sponsor)
Alzheimer s Disease, Mild Cognitive Impairment, Healthy
Related terms Cognitive Dysfunction
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov